MSD becomes a healthcare partner of the Women's National Football Team 20/02/2026 Healthcare The aim of this alliance is to promote social awareness of human papillomavirus, the most common sexually transmitted... Partners - MSD
ORYZON receives European Medicines Agency approval to initiate a Phase II study of iadadem... 24/02/2026 Healthcare Innovative drugs Essential thrombocythemia is the most common type of myeloproliferative neoplasm (MPN) and is associated with an... Partners - Oryzon Genomics
The impact of digital twins on personalised medicine 20/02/2026 Healthcare Personalized medicine Digital twins make it possible to simulate personalised clinical scenarios without intervening directly on the patient... Partners - GENESIS Biomed
Klinea strengthens its growth in the cosmetics industry through a strategic alliance with ... 18/02/2026 Healthcare The incorporation of advanced biotechnological assets—such as proteins, peptides, fermented products, or cell... Partners - Klinea Biotech & Pharma Engineering
Childhood Cancer Needs Greater Awareness and Stable Funding to Accelerate Innovative Thera... 15/02/2026 Healthcare Access to innovation Innovative drugs Personalized medicine Advanced therapies Marina Salmón, Head of Project Evaluation at the Scientific Foundation of the Spanish Association Against Cancer, a... AseBio - Fundación Científica de la Asociación Española Contra el Cáncer
Childhood Cancer Needs Greater Awareness and Stable Funding to Accelerate Innovative Thera... 15/02/2026 Fundación Científica de la Asociación Española Contra el Cáncer In Spain, around 1,500 cases of childhood cancer are diagnosed each year (1% of the total), making research more... AseBio - Fundación Científica de la Asociación Española Contra el Cáncer
Gyala Therapeutics initiates Phase I/IIa clinical trial of a CAR-T cell therapy for acute ... 10/02/2026 Healthcare Advanced therapies The study has been initiated at Hospital La Fe in Valencia and Hospital Clínic Barcelona, two internationally recognized... Partners - Invivo Partners, S.G.E.I.C, S.A
ORYZON announces appointment of Rolando Gutierrez-Esteinou, M.D., as Chief Medical Officer... 12/02/2026 Healthcare Talento Based in New Jersey (USA), to lead ORYZON’s CNS clinical development. Partners - Oryzon Genomics
ORYZON announces first patient dosed in an Investigator-initiated Phase Ib study of iadade... 09/02/2026 Healthcare Innovative drugs The study, led by Yale University, explore the combination with atezolizumab and radiation therapy. Partners - Oryzon Genomics
